Medical Developments International | MVP - SCHULD

Aktienkurs
0.38
Täglich Wechseln
0 0%
Monatlich
0%
Jährlich
-11.76%
Q2 Prognose
0.37




SCHULD Veränderung Datum
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Avita Medical AUD 46.05M 1.46M 2025-12
Clinuvel Pharmaceuticals AUD 879.78K 189.09K 2024-06
Dianthus Therapeutics USD 1.28M 45K 2025-09
Genetic Signatures AUD 791K 223K 2025-06
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
Medical Developments International AUD 1.99M 152K 2025-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Organon & Co USD 8.83B 68M 2025-09
Paradigm Biopharmaceuticals AUD 181.4K 38.99K 2024-12
PYC Therapeutics AUD 1.02M 185.07K 2025-06
Starpharma Holdings AUD 2.4M 73K 2025-06
Tectonic Therapeutic USD 876K 115K 2024-12
Telix Pharmaceuticals AUD 418.25M 163.2M 2025-06
Viatris USD 14.41B 25.6M 2025-12
Xeris Pharmaceuticals USD 257.65M 431K 2025-09